Literature DB >> 32808969

Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.

Mitchell H Katz1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32808969     DOI： 10.1001/jamainternmed.2020.4624

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody.

Authors:  Giovanna Moscato; Paola Mazzetti; Ersilia Lucenteforte; Alfredo Rosellini; Alice Cara; Paola Quaranta; Valerio Mainardi; Pietro Villa; Daniele Focosi; Maria Lanza; Irene Bianco; Alessandro Mazzoni; Marco Falcone; Francesco Menichetti; Fabrizio Maggi; Michele Lai; Giulia Freer; Mauro Pistello
Journal:  J Clin Virol Plus       Date:  2021-05-04

2.  A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.

Authors:  Silvano Wendel; Rita Fontão-Wendel; Roberta Fachini; Gabriela Candelaria; Patricia Scuracchio; Ruth Achkar; Mayra Brito; Luiz Fernando Reis; Anamaria Camargo; Mariane Amano; Rafael Machado; Danielle Araujo; Camila Soares; Edison Durigon
Journal:  Transfusion       Date:  2021-02-19       Impact factor: 3.337

3.  A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers.

Authors:  Ronan Garlantézec; Christopher Heslan; Emilie Tadie; Pierre Tattevin; Vincent Thibault; Christophe Paris
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.